E-LIB Suche - Ergebnisse für: Fleming, Thomas R

1

Monitoring overall survival in pivotal trials in indolent c..:

Fleming, Thomas R ; Hampson, Lisa V ; Bharani, Bharani-Dharan...
Statistics in Biopharmaceutical Research. , 2024

Link: https://doi.org/10.1080/..

2

Methods for the estimation of direct and indirect vaccinati..:

Wang, Rui ; Cen, Mengqi ; Huang, Yunda...
Statistics in Medicine. 43 (2024) 8 - p. 1627-1639 , 2024

Link: https://doi.org/10.1002/..

3

Moving forward in IPF: lessons learned from clinical trials:

Raghu, Ganesh ; Fleming, Thomas R
The Lancet Respiratory Medicine. , 2024

Link: https://doi.org/10.1016/..

4

Training the Next Generation of Data Monitoring Committee M..:

Fleming, Thomas R. ; Wittes, Janet ; Fiuzat, Mona...
JACC: Heart Failure. , 2024

Link: https://doi.org/10.1016/..

5

Finding the (biomarker-defined) subgroup of patients who be..:

McShane, Lisa Meier ; Rothmann, Mark D ; Fleming, Thomas R
Clinical Trials. 20 (2023) 4 - p. 341-350 , 2023

Link: https://doi.org/10.1177/..

6

A platform trial design for preventive vaccines against Mar..:

Longini, Ira M ; Yang, Yang ; Fleming, Thomas R...
Clinical Trials. 19 (2022) 6 - p. 647-654 , 2022

Link: https://doi.org/10.1177/..

7

An introduction to the Marburg virus vaccine consortium, MA..:

Cross, Robert W. ; Longini, Ira M. ; Becker, Stephan...
PLOS Pathogens. 18 (2022) 10 - p. e1010805 , 2022

Link: https://doi.org/10.1371/..

8

Reliably Assessing Duration of Protection for Coronavirus D..:

Lin, Dan-Yu ; Zeng, Donglin ; Gu, Yu..
The Journal of Infectious Diseases. 226 (2022) 11 - p. 1863-1866 , 2022

Link: https://doi.org/10.1093/..

9

FDA/Arthritis Foundation osteoarthritis drug development wo..:

Kim, Jason S. ; Borges, Silvana ; Clauw, Daniel J....
Seminars in Arthritis and Rheumatism. 56 (2022) - p. 152070 , 2022

Link: https://doi.org/10.1016/..

10

Innovations in Pediatric Therapeutics Development: Principl..:

Fleming, Thomas R. ; Garnett, Christine E. ; Conklin, Laurie S....
Therapeutic Innovation & Regulatory Science. 57 (2022) 1 - p. 109-120 , 2022

Link: https://doi.org/10.1007/..

11

Evaluating group-sequential non-inferiority clinical trials..:

Hanscom, Brett S ; Donnell, Deborah J ; Fleming, Thomas R...
Clinical Trials. 19 (2022) 6 - p. 605-612 , 2022

Link: https://doi.org/10.1177/..

12

Considerations in boosting COVID-19 vaccine immune response:

Krause, Philip R ; Fleming, Thomas R ; Peto, Richard...
The Lancet. 398 (2021) 10308 - p. 1377-1380 , 2021

Link: https://doi.org/10.1016/..

13

COVID-19 vaccine trials: The potential for "hybrid" analyse:

Fleming, Thomas R ; Nason, Martha ; Krause, Philip R..
Clinical Trials. 18 (2021) 4 - p. 391-397 , 2021

Link: https://doi.org/10.1177/..

14

COVID-19 vaccine trials: The use of active controls and non..:

Fleming, Thomas R ; Krause, Philip R ; Nason, Martha..
Clinical Trials. 18 (2021) 3 - p. 335-342 , 2021

Link: https://doi.org/10.1177/..

15

Achieving effective informed oversight by DMCs in COVID cli..:

DeMets, David L. ; Fleming, Thomas R.
Journal of Clinical Epidemiology. 126 (2020) - p. 167-171 , 2020

Link: https://doi.org/10.1016/..